Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bladder Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01444456
What this trial is testing

Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia

Who this might be right for
AnemiaBreast CancerCancer+11 more
Amgen 1,262
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Post-approval studies (Phase 4)Study completedNCT02214602
What this trial is testing

Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer

Who this might be right for
Carcinoma of Urinary Bladder, Superficial
Mansoura University 240
Testing effectiveness (Phase 2)Looking for participantsNCT05951179
What this trial is testing

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle Invasive Bladder Cancer
Protara Therapeutics 131
Not applicableStudy completedNCT02861196
What this trial is testing

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 59
Testing effectiveness (Phase 2)Looking for participantsNCT06394570
What this trial is testing

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

Who this might be right for
Bladder Cancer
University of Texas Southwestern Medical Center 19
Testing effectiveness (Phase 2)Looking for participantsNCT07475403
What this trial is testing

Urinary Tumor DNA-Guided Systemic Immunotherapy for Unresectable Very-High-Risk Non-Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerLiquid BiopsyImmunotherapy
Tianjin Medical University Second Hospital 53
Testing effectiveness (Phase 2)Study completedNCT03980041
What this trial is testing

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

Who this might be right for
Bladder CancerUrothelial CarcinomaSolid Tumor+1 more
Infinity Pharmaceuticals, Inc. 49
Very early researchStudy completedNCT04018053
What this trial is testing

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Who this might be right for
Bladder CancerUrothelial Carcinoma
Brigham and Women's Hospital 16
Testing effectiveness (Phase 2)WithdrawnNCT05120622
What this trial is testing

Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancer

Who this might be right for
Bladder CancerHigh-Risk CancerTremelimumab+2 more
University of British Columbia
Testing effectiveness (Phase 2)Study completedNCT04133051
What this trial is testing

Perioperative Analgesic Efficiency of Quadratus Lumborum Block vs Epidural in Radical Cystectomy

Who this might be right for
Pain, Postoperative
National Cancer Institute, Egypt 34
Not applicableLooking for participantsNCT07036731
What this trial is testing

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

Who this might be right for
Non Muscle Invasive Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University 428
Not applicableUnknownNCT05611762
What this trial is testing

Narrow-band Imaging Diagnostic Classification System for Bladder Tumors

Who this might be right for
Urinary Bladder Neoplasms
Qilu Hospital of Shandong University (Qingdao) 1,064
Not applicableUnknownNCT03673202
What this trial is testing

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

Who this might be right for
Bladder Cancer
London Health Sciences Centre 300
Not applicableUnknownNCT05480735
What this trial is testing

EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy

Who this might be right for
Bladder Carcinoma
The Netherlands Cancer Institute 154
Not applicableStudy completedNCT00859768
What this trial is testing

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

Who this might be right for
Breast CancerLung CancerProstate Cancer+6 more
Netherlands Open University 568
Early research (Phase 1)Study completedNCT02300610
What this trial is testing

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Who this might be right for
Bladder CancerCarcinoma, Transitional CellRenal Pelvis Cancer+2 more
H. Lee Moffitt Cancer Center and Research Institute 10
Not applicableStudy completedNCT07402317
What this trial is testing

Trimodality Bladder Preservation

Who this might be right for
Bladder Cancer Treatment
Al-Azhar University 97
Large-scale testing (Phase 3)Study completedNCT00006124
What this trial is testing

Celecoxib in Treating Patients With Bladder Cancer

Who this might be right for
Recurrent Bladder Cancer
National Cancer Institute (NCI) 152
Early research (Phase 1)Looking for participantsNCT07359235
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in Bladder Cancer (BC)

Who this might be right for
Bladder Cancer (BC)
Tongji Hospital 29
Next Page